Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cediranib is a potent and selective inhibitor of VEGF with antineoplastic activities. It inhibits all three vascular endothelial growth factor receptor (VEGF-1,-2,-3) tyrosine kinases, thereby blocking VEGF-signaling, angiogenesis, and tumor cell growth.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 32.00 | |
5 mg | 5 days | $ 49.00 |
Description | Cediranib is a potent and selective inhibitor of VEGF with antineoplastic activities. It inhibits all three vascular endothelial growth factor receptor (VEGF-1,-2,-3) tyrosine kinases, thereby blocking VEGF-signaling, angiogenesis, and tumor cell growth. |
Targets&IC50 | c-Kit:2 nM (IC50), PDGFRβ:5 nM (IC50), PDGFRα:36 nM (IC50), FLT4:3 nM (IC50), FLK1:5 nM (IC50), KDR:1 nM (IC50) |
Synonyms | AZD-2171, Recentin, AZD2171, AZD2171 maleate, AZD 2171 |
Molecular Weight | 566.58 |
Formula | C29H31FN4O7 |
CAS No. | 857036-77-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cediranib maleate 857036-77-2 AZD2171 Maleate AZD-2171 Maleate Cediranib Maleate AZD-2171 Recentin AZD 2171 Maleate AZD2171 AZD2171 maleate AZD 2171 inhibitor inhibit